Targeting FLT3 as therapy for leukemia.

被引：0
|
作者：
Small, D [1 ]
Levis, M [1 ]
Smith, D [1 ]
Zheng, R [1 ]
Allebach, J [1 ]
Chen, P [1 ]
Kim, KT [1 ]
Li, L [1 ]
Ahn, J [1 ]
Brown, P [1 ]
Piloto, O [1 ]
Perl, A [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6268S / 6269S
页数：2
相关论文
共 50 条
  • [31] Targeting FLT3 kinase in acute myelogenous leukemia: Progress, perils, and prospects
    Heinrich, MC
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (03) : 255 - 271
  • [32] Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
    Melat T. Gebru
    Hong-Gang Wang
    Journal of Hematology & Oncology, 13
  • [33] Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
    Gebru, Melat T.
    Wang, Hong-Gang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [34] Internal tandem duplication of the FLT3 gene in acute leukemia: Clinical and prognostic implications in acute myeloid leukemia.
    Chi, HS
    Yang, SE
    Choi, SJ
    Park, CJ
    Seo, EJ
    Lee, KH
    BLOOD, 2000, 96 (11) : 104A - 104A
  • [35] Prognostic significance of FLT3 mutations in pediatric non-promyeloytic acute myeloid leukemia.
    Kang, HJ
    Hong, SH
    Kim, IH
    Park, BK
    Han, KS
    Cho, HI
    Shin, HY
    Ahn, HS
    BLOOD, 2004, 104 (11) : 182B - 182B
  • [36] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Bartholomew J. Eisfelder
    Caner Saygin
    Joseph Wynne
    Margaret W. Colton
    Mariafausta Fischietti
    Elspeth M. Beauchamp
    Jason X. Cheng
    Olatoyosi Odenike
    Gail Roboz
    Houda Alachkar
    Wendy Stock
    Blood Cancer Journal, 11
  • [37] PIM: An Integral Component of FLT3 Signaling and a Potential Therapeutic Target in Acute Myeloid Leukemia.
    Fathi, Amir T.
    Swinnen, Ian
    Rajkhowa, Trivikram
    Small, Donald
    Marmsater, Fredrik
    Robinson, John E.
    Gross, Stefan David
    Martinson, Matthew
    Allen, Shelley
    Kallan, Nick
    Levis, Mark
    BLOOD, 2009, 114 (22) : 690 - 690
  • [38] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Eisfelder, Bartholomew J.
    Saygin, Caner
    Wynne, Joseph
    Colton, Margaret W.
    Fischietti, Mariafausta
    Beauchamp, Elspeth M.
    Cheng, Jason X.
    Odenike, Olatoyosi
    Roboz, Gail
    Alachkar, Houda
    Stock, Wendy
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [39] Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
    Wang, Eunice S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 154 - 162
  • [40] Proteosomal degradation of Flt3 is stimulated by leukemia-associated Flt3 mutations.
    Robinson, LJ
    Xue, J
    BLOOD, 2004, 104 (11) : 705A - 705A
12345